Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65)

Diabetes Metab J. 2023 Sep;47(5):717-718. doi: 10.4093/dmj.2023.0300. Epub 2023 Sep 26.

Authors

Hye Jun Kim¹, Sung Ryul Shim², Myunghee Hong^{3

4}, Hyun Wook Han⁴

Affiliations

¹ Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
² Department of Biomedical Informatics, Konyang University College of Medicine, Daejeon, Korea.
³ Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Korea.
⁴ Institute of Biomedical Informatics, CHA University School of Medicine, Seongnam, Korea.

No abstract available

Publication types

Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / epidemiology
COVID-19* / prevention & control
Data Analysis
Diabetes Mellitus, Type 2* / epidemiology
Humans
Hypoglycemic Agents

Substances

COVID-19 Vaccines
Hypoglycemic Agents